BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23664880)

  • 1. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
    Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
    Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
    Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel series of 4-quinolone JNK inhibitors.
    Gong L; Tan YC; Boice G; Abbot S; McCaleb K; Iyer P; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Lukacs CM; Ursula Kammlott R; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7381-7. PubMed ID: 23142618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.
    Kamenecka T; Jiang R; Song X; Duckett D; Chen W; Ling YY; Habel J; Laughlin JD; Chambers J; Figuera-Losada M; Cameron MD; Lin L; Ruiz CH; LoGrasso PV
    J Med Chem; 2010 Jan; 53(1):419-31. PubMed ID: 19947601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
    Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM; Huerta F; Kallin E; Malmström J; Weigelt T; Viklund J; Womack P; Xue Y; Ohberg L
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5095-9. PubMed ID: 16140012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies.
    Liu M; Wang S; Clampit JE; Gum RJ; Haasch DL; Rondinone CM; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
    Bioorg Med Chem Lett; 2007 Feb; 17(3):668-72. PubMed ID: 17107797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Alam M; Beevers RE; Ceska T; Davenport RJ; Dickson KM; Fortunato M; Gowers L; Haughan AF; James LA; Jones MW; Kinsella N; Lowe C; Meissner JW; Nicolas AL; Perry BG; Phillips DJ; Pitt WR; Platt A; Ratcliffe AJ; Sharpe A; Tait LJ
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3463-7. PubMed ID: 17459703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the c-Jun N-Terminal Kinase Inhibitor
    Nagy MA; Hilgraf R; Mortensen DS; Elsner J; Norris S; Tikhe J; Yoon W; Paisner D; Delgado M; Erdman P; Haelewyn J; Khambatta G; Xu L; Romanow WJ; Condroski K; Bahmanyar S; McCarrick M; Benish B; Blease K; LeBrun L; Moghaddam MF; Apuy J; Canan SS; Bennett BL; Satoh Y
    J Med Chem; 2021 Dec; 64(24):18193-18208. PubMed ID: 34894681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of c-Jun N-terminal kinases: an update.
    Koch P; Gehringer M; Laufer SA
    J Med Chem; 2015 Jan; 58(1):72-95. PubMed ID: 25415535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
    Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
    Wolle P; Hardick J; Cronin SJF; Engel J; Baumann M; Lategahn J; Penninger JM; Rauh D
    J Med Chem; 2019 Mar; 62(5):2843-2848. PubMed ID: 30768270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule JNK (c-Jun N-terminal kinase) inhibitors.
    Siddiqui MA; Reddy PA
    J Med Chem; 2010 Apr; 53(8):3005-12. PubMed ID: 20146479
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.
    Ngoei KR; Catimel B; Milech N; Watt PM; Bogoyevitch MA
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1939-50. PubMed ID: 23792175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
    Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.
    Pastor RM; Burch JD; Magnuson S; Ortwine DF; Chen Y; De La Torre K; Ding X; Eigenbrot C; Johnson A; Liimatta M; Liu Y; Shia S; Wang X; Wu LC; Pei Z
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2448-52. PubMed ID: 24767842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of c-jun-N-terminal kinase (JNK).
    LoGrasso P; Kamenecka T
    Mini Rev Med Chem; 2008 Jul; 8(8):755-66. PubMed ID: 18673131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pyrrolo[2,3-g]indazoles as new Pim kinase inhibitors.
    Gavara L; Suchaud V; Nauton L; Théry V; Anizon F; Moreau P
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2298-301. PubMed ID: 23499503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.